A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

NCT07511114 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

156

Enrollment

OTHER

Sponsor class

Conditions

DLBCL - Diffuse Large B Cell Lymphoma
Double Expressor Lymphoma

Interventions

DRUG: C-Pola-R-CHP+X
DRUG: CR-CHOP

Sponsor

Ruijin Hospital